MYUNGMOON Pharm co.,Ltd (KRX:017180)

MYUNGMOON Pharm co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	60,405	61,842	60,806	76,621	97,023	159,901
Market Cap Growth	11.75%	1.70%	-20.64%	-21.03%	-39.32%	-34.94%
Enterprise Value	158,610	157,281	151,088	159,448	175,770	244,712
Last Close Price	1807.00	1850.00	1819.00	2285.00	2870.00	4730.00
PE Ratio	31.70	32.63	-	-	12.33	-
PS Ratio	0.31	0.32	0.33	0.45	0.64	1.16
PB Ratio	0.58	0.59	0.59	0.86	1.02	1.86
P/TBV Ratio	0.61	0.63	0.63	0.92	1.09	2.00
P/FCF Ratio	-	-	-	-	25.91	332.93
P/OCF Ratio	-	-	-	-	17.72	187.02
EV/Sales Ratio	0.81	0.81	0.81	0.94	1.16	1.78
EV/EBITDA Ratio	14.69	14.57	25.21	31.07	16.47	-
EV/EBIT Ratio	23.21	23.01	78.34	165.44	27.32	-
EV/FCF Ratio	-18.74	-	-	-	46.95	509.51
Debt / Equity Ratio	0.94	0.94	0.85	1.02	0.87	0.98
Debt / EBITDA Ratio	9.14	9.14	14.60	17.63	7.79	-
Debt / FCF Ratio	-	-	-	-	22.21	175.17
Net Debt / Equity Ratio	0.89	0.89	0.80	0.89	0.77	0.86
Net Debt / EBITDA Ratio	8.57	8.57	13.80	15.36	6.86	-43.87
Net Debt / FCF Ratio	-10.93	-10.93	-39.23	-9.65	19.54	153.27
Asset Turnover	0.74	0.74	0.75	0.73	0.67	0.59
Inventory Turnover	2.49	2.49	2.60	2.67	2.88	2.70
Quick Ratio	0.55	0.55	0.51	0.42	0.39	0.36
Current Ratio	0.96	0.96	0.87	0.70	0.64	0.60
Return on Equity (ROE)	1.37%	1.37%	-3.95%	-5.30%	8.81%	-7.70%
Return on Assets (ROA)	1.61%	1.61%	0.49%	0.26%	1.77%	-1.58%
Return on Invested Capital (ROIC)	1.88%	1.91%	1.09%	0.57%	3.92%	-3.50%
Return on Capital Employed (ROCE)	3.90%	3.90%	1.20%	0.80%	5.40%	-5.30%
Earnings Yield	3.14%	3.06%	-4.99%	-5.91%	8.11%	-4.29%
FCF Yield	-14.01%	-13.68%	-3.47%	-10.65%	3.86%	0.30%
Buyback Yield / Dilution	0.29%	0.29%	0.99%	0.38%	-	-15.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.